A Multicenter Randomised Study Comparing the Efficacy of PegIFN-alfa2a Plus Placebo vs. PegIFN-alfa2a Plus Tenofovir for the Treatment of Chronic Delta Hepatitis-The Hep-Net International Delta Hepatitis Interventional Trial II (HIDIT-II).
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2017
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Peginterferon alfa-2a
- Indications Hepatitis D
- Focus Therapeutic Use
- Acronyms HIDIT-2; HIDIT-II
- 26 Aug 2017 This trial has been completed in Germany as reported by European Clinical Trials Database.
- 25 Aug 2017 Status changed from active, no longer recruiting to completed.
- 03 Nov 2013 Results of a 96-week analysis presented at the 64th Annual Meeting of the American Association for the Study of Liver Diseases.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History